YTX-465
YTX-465 is a stearoyl-CoA desaturase (Ole1/SCD) inhibitor. YTX-465 inhibits Ole1 and SCD1 with IC50s of 0.039 μM and 30.4 μM, respectively. YTX-465 can be used in the research of Parkinson’s disease and other synucleinopathies[1].
Product Specifications
CAS Number
[2225824-53-1]
UNSPSC
12352005
Target
Stearoyl-CoA Desaturase (SCD)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ytx-465.html
Purity
99.06
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NCC(N1CCC(C2=NC(C3=CC4=C(C=C3)C(C)=NN4C)=NO2)CC1)=O)C5=CC=CC=C5
Molecular Formula
C25H26N6O3
Molecular Weight
458.51
References & Citations
[1]Vincent BM, et al. Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity. Cell Rep. 2018 Dec 4;25 (10) :2742-2754.e31.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
25-Cyclohexyl-4'-O-de (2, 6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl) -5-demethoxy-25-de (1-methylpropyl) -5-oxo-avermectin A1a
25-Cyclohexyl-4'-O-de (2, 6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl) -5-demethoxy-25-de (1-methylpropyl) -5-oxo-avermectin A1a
